Slpi - secretory leukocyte peptidase inhibitor Gene
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 84386
Summary
Predicted to enable enzyme binding activity; nucleic acid binding activity; and serine-type endopeptidase inhibitor activity. Involved in negative regulation of inflammatory response. Predicted to be located in Golgi apparatus. Predicted to be active in extracellular space. Biomarker of chronic obstructive pulmonary disease; endophthalmitis; middle cerebral artery infarction; myocardial infarction; and polycystic ovary syndrome. Orthologous to human SLPI (secretory leukocyte peptidase inhibitor). [provided by Alliance of Genome Resources, Apr 2022]
Slpi Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_053372.2 | NP_445824.2 | secretory leukocyte peptidase inhibitor precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
secretory leukocyte peptidase inhibitor |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS13382 | SLPI Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS17168 | Slpi Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23618 | Slpi Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service